These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 17868433)

  • 101. [The time has come to change the influenza vaccination strategy].
    Kiro A; Mor Z
    Harefuah; 2008 Dec; 147(12):993-4, 1028. PubMed ID: 19260598
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Special immunization considerations of the preterm infant.
    Gad A; Shah S
    J Pediatr Health Care; 2007; 21(6):385-91. PubMed ID: 17980805
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Current developments in new vaccines for adolescents.
    Rappuoli R
    Biologicals; 1997 Jun; 25(2):159-63. PubMed ID: 9236045
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
    Chevallier B; Vesikari T; Brzostek J; Knuf M; Bermal N; Aristegui J; Borys D; Cleerbout J; Lommel P; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S109-18. PubMed ID: 19325447
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Prevention of viral hepatitis in the Nordic countries and Germany.
    Fitzsimons D; François G; Alpers K; Radun D; Hallauer J; Jilg W; Gerlich W; Rombo L; Blystad H; Nøkleby H; van Damme P
    Scand J Infect Dis; 2005; 37(8):549-60. PubMed ID: 16099768
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Hepatitis A: how benign is it?
    Shovein JT; Damazo RJ; Hyams I
    Am J Nurs; 2000 Mar; 100(3):43-7; quiz 47-8. PubMed ID: 10738401
    [No Abstract]   [Full Text] [Related]  

  • 108. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
    [TBL] [Abstract][Full Text] [Related]  

  • 109. [Hepatitis in perinatology and pediatrics. Prevention and vaccination].
    Alagille D
    Rev Med Liege; 1984 Oct; 39(20):709-21. PubMed ID: 6390599
    [No Abstract]   [Full Text] [Related]  

  • 110. An update on viral hepatitis.
    Irshad M; Acharya SK
    Trop Gastroenterol; 1992; 13(1):11-20. PubMed ID: 1413093
    [No Abstract]   [Full Text] [Related]  

  • 111. [Immunoprophylaxis of viral hepatitis].
    Cervera Solórzano J
    Rev Gastroenterol Mex; 1988; 53(3):193-9. PubMed ID: 3057578
    [No Abstract]   [Full Text] [Related]  

  • 112. [Hepatitis B and C: in view of the treatment options, priority should be given to reaching the groups at risk].
    de Man RA
    Ned Tijdschr Geneeskd; 2007 Oct; 151(43):2365-6. PubMed ID: 18019211
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Progress in timely vaccination coverage among children living in low-income households.
    Smith PJ; Jain N; Stevenson J; Männikkö N; Molinari NA
    Arch Pediatr Adolesc Med; 2009 May; 163(5):462-8. PubMed ID: 19414693
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program.
    Chodick G; Heymann AD; Ashkenazi S; Kokia E; Shalev V
    J Viral Hepat; 2008 Oct; 15 Suppl 2():62-5. PubMed ID: 18837837
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Progress toward achieving the 1990 immunization objectives.
    Hinman AR; Jordan WS
    Public Health Rep; 1983; 98(5):436-43. PubMed ID: 6444194
    [TBL] [Abstract][Full Text] [Related]  

  • 116. [Future vaccines].
    Tron F
    Rev Prat; 1995 Jun; 45(12):1514-9. PubMed ID: 7660007
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Viral hepatitis--1993: an update.
    Schiff E
    Med Sect Proc; 1993; ():181-93. PubMed ID: 7521529
    [No Abstract]   [Full Text] [Related]  

  • 118. Immunogenecity of hepatitis A vaccine in children below 2 years of age.
    Mittal SK; Rastogi A
    Indian Pediatr; 1999 Jan; 36(1):97. PubMed ID: 10709135
    [No Abstract]   [Full Text] [Related]  

  • 119. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines.
    Schattner A
    Vaccine; 2005 Jun; 23(30):3876-86. PubMed ID: 15917108
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Prevention of viral hepatitis in Italy.
    FitzSimons D; François G; Bonanni P; Mele A; Zanetti A; Stroffolini T; Crovari P; Van Damme P
    Vaccine; 2004 Sep; 22(29-30):4092-6. PubMed ID: 15364461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.